Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...
Eli Lilly plans to invest $27 billion in new U.S. plants amidst threats of drug import tariffs by the Trump administration.
Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.
Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...
Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...
At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...
Eli Lilly announces plans to build four new U.S. manufacturing facilities, enhancing domestic pharmaceutical production and creating jobs.
Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by ...
The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results